Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Opioids
Biotech
Eagle swoops down to nab chunk of BARDA-backed Enalare
Eagle Pharmaceuticals is swooping down to take a chunk out of Enalare Therapeutics, paying up to $55 million in equity to the BARDA-backed company.
Max Bayer
Aug 9, 2022 11:22am
Dissolving, nerve-cooling device offers drug-free pain relief
Jul 1, 2022 10:22am
Will addiction tech curb soaring opioid overdose deaths?
Mar 21, 2022 9:15am
FDA OKs Saluda's spinal cord stimulation tech for chronic pain
Mar 9, 2022 10:15am
Pear nabs FDA breakthrough tag for alcoholism digital therapy
Nov 22, 2021 11:55am
Non-opioid pain drug indirectly blocks a key ion channel
Nov 10, 2021 2:00pm